HPN601
HPN601 is a monoclonal antibody targeting CD326/EPCAM, as well as a protease-activated EpCAM-targeted T cell engager. HPN601 binds to EPCAM, CD3e and albumin, and induces T cell-mediated tumor cell killing. HPN601 significantly reduces the release levels of IFN-γ, IL-2, IL-6, and IL-10. HPN601 can be used for relevant research on cancers such as breast cancer and gastric cancer.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human
|
IL-2 |
IL-6 |
IL-10 |
HPN601 demonstrates a tenfold improved therapeutic window compared to a constitutively active EpCAM-targeting T cell engager and significantly attenuates cytokine production including IFN-γ, IL-2, IL-6, and IL-10 in non-human primates[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
EpCAM/TROP1/CD326
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)